This article is a correction to:
Kidney disease in adults with Prader-Willi syndrome: international cohort study and systematic literature review
Denise H. van Abswoude1,2,3,4
Karlijn Pellikaan1,2,3,4Naomi Nguyen1Anna G. W. Rosenberg1,2,3,4Kirsten Davidse1,2,3,4Franciska M. E. Hoekstra1,5Ilse M. Rood6Christine Poitou7,8,9Graziano Grugni8,9,10Charlotte Høybye8,9,11,12Tania P. Markovic8,13,14Assumpta Caixàs8,15,16Antonino Crinò8,17,18Sjoerd A. A. van den Berg1,19Aart J. van der Lely1,2,4Laura C. G. de Graaff1,2,3,4,9*- 1Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, Netherlands
- 2Center for Adults with Rare Genetic Syndromes, Department of Internal Medicine, Division of Endocrinology, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, Netherlands
- 3Dutch Center of Reference for Prader–Willi Syndrome, Rotterdam, Netherlands
- 4Academic Center for Growth Disorders, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, Netherlands
- 5Internal Medicine, Division of Nephrology, Reinier de Graaf Gasthuis, Delft, Netherlands
- 6Department of Nephrology, Radboud University Medical Center, Radboud Institute for Health Sciences, Nijmegen, Netherlands
- 7Assistance Publique-Hôpitaux de Paris, Rare Diseases Center of Reference ‘Prader-Willi Syndrome and Obesity with Eating Disorders’ (PRADORT), Nutrition Department, Institute of Cardiometabolism and Nutrition (ICAN), Pitié-Salpêtrière Hospital, Sorbonne Université, National Institute of Health and Medical Research (INSERM), Nutriomics, Paris, France
- 8International Network for Research, Management & Education on adults with Prader-Willi Syndrome (INfoRMEd-PWS)
- 9European Reference Network on Rare Endocrine Conditions (ENDO-ERN)
- 10Division of Auxology, Istituto Auxologico Italiano, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Piancavallo, Italy
- 11Department of Molecular Medicine and Surgery, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden
- 12Department of Endocrinology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden
- 13Metabolism & Obesity Service, Royal Prince Alfred Hospital, Camperdown, NSW, Australia
- 14Charles Perkins Center and Sydney Medical School, University of Sydney, Sydney, NSW, Australia
- 15Department of Endocrinology and Nutrition, Parc Tauli Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT) Instituto de Salud Carlos III (CERCA-ISCIII), Sabadell, Spain
- 16Department of Medicine, Universitat Autònoma de Barcelona, Sabadell, Spain
- 17Reference Center for Prader-Willi syndrome, Bambino Gesù Hospital, Research Institute, Palidoro, Italy
- 18Center for Rare Diseases and Congenital Defects, Fondazione Policlinico Universitario A. Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Rome, Italy
- 19Department of Clinical Chemistry, Erasmus Medical Center (MC), University Medical Center Rotterdam, Rotterdam, Netherlands
A Corrigendum on:
Kidney disease in adults with Prader-Willi syndrome: international cohort study and systematic literature review.
By van Abswoude DH, Pellikaan K, Nguyen N, Rosenberg AGW, Davidse K, Hoekstra FME, Rood IM, Poitou C, Grugni G, Høybye C, Markovic TP, Caixàs A, Crinò A, van den Berg SAA, van der Lely AJ and de Graaff LCG (2023) Front. Endocrinol. 14:1168648. doi: 10.3389/fendo.2023.1168648
In the published article, there was an error in Table 4 as published. The results of the article by Van Nieuwpoort et al. (2018) were displayed as “Median [IQR] urine creatinine in the total cohort 1.74 [1.47] mmol/24 h, no significant difference was found in males 3.27 [2.86] mmol/24 h compared to females 1.70 [0.69] mmol/24 h.” The correct statement is “Median [IQR] urine creatinine in the total cohort 1.74 [1.47] mmol/2 h, no significant difference was found in males 3.27 [2.86] mmol/2 h compared to females 1.70 [0.69] mmol/2 h”. The corrected Table 4 and its caption appear below.
Table 4
Table 4 Results of studies reporting on PWS and kidney diseases with more than one patient.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: Prader-Willi Syndrome, kidney function tests, proteinuria, urine tract infections, cardiovascular disease, kidney disease
Citation: van Abswoude DH, Pellikaan K, Nguyen N, Rosenberg AGW, Davidse K, Hoekstra FME, Rood IM, Poitou C, Grugni G, Høybye C, Markovic TP, Caixàs A, Crinò A, van den Berg SAA, van der Lely AJ and de Graaff LCG (2024) Corrigendum: Kidney disease in adults with Prader-Willi syndrome: international cohort study and systematic literature review. Front. Endocrinol. 15:1357219. doi: 10.3389/fendo.2024.1357219
Received: 19 December 2023; Accepted: 04 January 2024;
Published: 22 January 2024.
Edited and Reviewed by:
Lovro Lamot University of Zagreb, CroatiaCopyright © 2024 van Abswoude, Pellikaan, Nguyen, Rosenberg, Davidse, Hoekstra, Rood, Poitou, Grugni, Høybye, Markovic, Caixàs, Crinò, van den Berg, van der Lely and de Graaff. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Laura C. G. de Graaff, l.degraaff@erasmusmc.nl